Current stock page

Stock Analysis

Celcuity Inc. (CELC) Stock Analysis

Celcuity Inc. (CELC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

CELC Stock Analysis Summary

Celcuity Inc. (CELC) currently has an AIQ Score of 41/100, indicating a bearish setup. Quality is the strongest factor at 63/100. Momentum is the weakest current factor at 24/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

CELC at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$64.37
AIQ Score41/100
Overall ViewBearish
Technical Analysis ConsensusStrong Sell
Market Cap$3.55B
P/E Ratio (TTM)-13.7
Forward P/E—
EPS (Q3 FY2026)-$1.33
Revenue (Q3 FY2026)$0
Dividend Yield (TTM)0.00%
Beta1.12
Volume646.5K
52-week range$53.54-$151.02
RSI 1443.22
50-Day SMA$72.47
200-Day SMA$98.45
Analyst Price Target$158.50
Next Earnings—
As of Nov 13, 2026 · Market close

CELCCelcuity Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

BearishEdge 6/10
$64.37+$0.20 (+0.31%)

Latest quote

  • Momentum
    24
  • Value
    —
  • Quality
    63
  • Risk resilience
    34
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

CELC Stock Analysis Summary

Celcuity Inc. (CELC) currently has an AIQ Score of 41/100, indicating a bearish setup. Quality is the strongest factor at 63/100. Momentum is the weakest current factor at 24/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, CELC has AIQ Score of 41/100 with Quality base of 63/100 and fading Momentum at 24/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Quality (63/100) leads while Momentum (24/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.31% stock move · CELC classified in Biotechnology.

Current Evidence

BearishCELC is in a bearish AIQ regime; Quality is the strongest visible factor at 63/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is CELC Bullish or Bearish Right Now?

CELC currently has a bearish overall setup. Quality is the strongest factor at 63/100, while Momentum is weakest at 24/100. The current evidence suggests a bearish setup.

Bull Case
  • - Analyst target implies +146.23% upside from the latest quote.
Bear Case
  • - Momentum is weak at 24/100.
  • - Risk Resilience is weak at 34/100.
  • - Price is -34.62% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (32 vs 6).

Current Consensus

CELC's Technical Analysis Consensus is currently Strong Sell, with 6 buy, 8 neutral, and 32 sell votes. CELC's 14-day RSI is 43.22, which places the stock in a weaker momentum range. CELC's beta is 1.12, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in CELC?

The largest recent change in CELC is Momentum moving down by 2.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.

AIQ Score
-1.0
Momentum
-2.0
Quality
+0.0
Risk
+0.0

What Would Change the CELC Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

CELC Decision Framework

Public evidence layers, setup checks, and risk context for Celcuity Inc..

Celcuity Inc. (CELC) Stock Analysis

Celcuity Inc. has an AIQ Score of 41/100 in a Bearish regime. Quality is strongest at 63/100. Beta is 1.12, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextCELC is in a Bearish AIQ regime with score 41/100.
Signal ConflictThe primary conflict is that quality leads at 63/100 while momentum lags at 24/100.
Factor EvidenceMomentum 24/100 · Quality 63/100 · Risk 34/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthWait

Quality is the strongest factor at 63/100.

TimingFail

Momentum is 24/100 and RSI (14) is 43.2.

Regime fitFail

CELC is in a Bearish regime at 41/100.

Risk controlFail

Risk factor is 34/100 with beta 1.12 and annual volatility 63.58%.

ConflictWait

Current conflict: quality leads at 63/100 while momentum lags at 24/100.

AIQ Score
41/100
Price
$64.37
Beta
1.12
RSI (14)
43.2

CELC Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

CELC Fundamentals

CELC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$0
Net income
-$73.34M
Free cash flow
-$66.51M
View full CELC fundamental analysis

CELC Technical Analysis

CELC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
43.22
Price vs SMA-50
-11.18%
View full CELC technical analysis

CELC Stock Catalysts

Track CELC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
—
Analyst target
$158.50
News items
5
View CELC earnings and stock catalysts

CELC Dividend Analysis

CELC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View CELC dividend history and analysis

CELC Financial Data

CELC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$0
EPS
-$1.33
Periods
8
View CELC financials

CELC Risk Analysis

CELC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.12
Risk score
34/100
1Y volatility
63.58%
View CELC risk analysis

CELC Stock News

CELC stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read CELC stock news

CELC vs Biotechnology Peers

Current peer cohort: CELC · CGON · CLDX · COGT · CYTK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
CELC
Current stock
41/100—24/10034/100-0.1963.58%Current
CGON
CG Oncology Inc.
59/100—71/10059/1001.3858.41%CELC vs CGON
CLDX
Celldex Therapeutics, Inc.
43/100—48/10055/1000.5552.44%CELC vs CLDX
COGT
Cogent Biosciences, Inc.
44/100—45/10051/100-0.2345.96%CELC vs COGT
CYTK
Cytokinetics, Incorporated
40/10041/10028/10056/100-0.2343.65%CELC vs CYTK
Pairwise Compare links: CGON · CLDX · COGT · CYTKCELC vs CGONCELC vs CLDXCELC vs COGTCELC vs CYTKCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a CELC stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for CELC: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-13.7
As of Nov 13, 2026
Revenue growth
—
Gross margin
0.00%
Current debt / equity
-10.2
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$0
Quarter net income
-$73.34M
Quarter free cash flow
-$66.51M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Mixed
RSI 14
43.22
MACD
-1.53

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
34/100
Beta
1.12
Annual volatility
63.58%
Max drawdown
-60.97%

CELC Stock FAQ

What is CELC stock price today?

Celcuity Inc.'s current stock price is $64.37. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is CELC bullish or bearish right now?

CELC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is CELC's market cap?

CELC's market cap is $3.55B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is CELC's current P/E ratio?

CELC's current P/E ratio is -13.7 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is CELC's RSI?

CELC's 14-day RSI is 43.22 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is CELC above its 50-day and 200-day moving averages?

CELC is -11.18% from its 50-day SMA and -34.62% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is CELC's next earnings date?

CELC's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does CELC pay a dividend?

CELC's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.